Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Genmab A/S (GMAB.CO) News - StockMarketCap

Stocks›Genmab A/S☆

● At closeAs of Jul 2, 2026

Genmab A/S

CPH: GMAB✓

HealthcareBiotechnologyCPH

$286.80DKK 1,874.00+4.11%

$17.61BMarket cap

20.91xP/E ratio

151.13KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$286.80DKK 1,874.00

$11.32 (+4.11%) · 24h

Key metrics

Market cap$17.61B+10.92%

Enterprise value$3.20B

Volume (24h)151.13K

P/E ratio (TTM)20.91x

P/S ratio (TTM)1.82x

Dividend yield0.00%

Shares outstanding61.39M

Trading range

Previous closeDKK 1,800.00

Day rangeDKK 1,800.00 - DKK 1,877.00

52-week rangeDKK 1,275.00 - DKK 2,257.00

Genmab A/S (GMAB.CO) operates in the Biotechnology industry within the Healthcare sector, listed on CPH.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news